Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CNOT8 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | EPHB4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | DDI2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | JDP2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | PSME1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | PDE4D | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | RNF183 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | PPIL4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | LEMD1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | OTOS | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |